Potent inhibitors of de novo pyrimidine and purine biosynthesis as chemotherapeutic agents
- 1 October 1990
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 10 (4) , 505-548
- https://doi.org/10.1002/med.2610100406
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Complex of N-phosphonacetyl-l-aspartate with aspartate carbamoyltransferaseJournal of Molecular Biology, 1988
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Induced maturation of the human promyelocytic leukemia cell line, HL-60, by 2-β-D-ribofuranosylselenazole-4-carboxamideBiochemical and Biophysical Research Communications, 1983
- Conversion of 2-β-D-ribofuranosylselenazole-4-carboxamide to an analogue of nad with potent imp dehydrogenase-inhibitory propertiesBiochemical Pharmacology, 1983
- Metabolic Resistance: The Protection of Enzymes against Drugs which are Tight‐Binding Inhibitors by the Accumulation of SubstrateEuropean Journal of Biochemistry, 1983
- Extreme state of ionization of benzylsuccinate bound by carboxypeptidase ABiochemistry, 1982
- Inhibition of thermolysin by N-carboxymethyl dipeptidesBiochemical and Biophysical Research Communications, 1981
- Chemical evidence for a functional carboxyl group in carboxypeptidase ABiochemical and Biophysical Research Communications, 1970
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957
- Analogs of Pteroylglutamic Acid. III. 4-Amino DerivativesJournal of the American Chemical Society, 1949